ACILAC Drug Patent Profile
✉ Email this page to a colleague
When do Acilac patents expire, and what generic alternatives are available?
Acilac is a drug marketed by Nostrum Labs and is included in one NDA.
The generic ingredient in ACILAC is lactulose. There are twenty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acilac
A generic version of ACILAC was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACILAC?
- What are the global sales for ACILAC?
- What is Average Wholesale Price for ACILAC?
Summary for ACILAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Patent Applications: | 3,586 |
| DailyMed Link: | ACILAC at DailyMed |
US Patents and Regulatory Information for ACILAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs | ACILAC | lactulose | SOLUTION;ORAL, RECTAL | 073685-001 | May 28, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
